{
    "code": 0,
    "data": [
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q3FY26 Earnings Call Audio",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=335657a9-dbd6-4214-a535-2a432b9b36f4.pdf",
            "news_date": "2026-02-12 18:28:09"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication cutouts Q3 - FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc67b72d-dbbd-4cbb-90a3-c887ae7809bd.pdf",
            "news_date": "2026-02-12 18:18:53"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine Months ended on December 31 2025.",
            "news_id": "52cff468-9657-4c89-bd8e-e85c982b8b52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6975260d-17bd-413a-a9cc-0f04f2b97a69.pdf",
            "news_date": "2026-02-11 23:04:28",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine Months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6975260d-17bd-413a-a9cc-0f04f2b97a69.pdf",
            "news_date": "2026-02-11 23:04:28"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Modified list of KMPs to determine materiality of an event or information and for making disclosure with stock exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc04dc6e-2c6b-4059-941f-67301908f70b.pdf",
            "news_date": "2026-02-11 20:45:06"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended On December On 31 2025",
            "news_body": "On review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine months ended on December 31 2025",
            "news_id": "cd29ccd5-448e-49ab-986d-633782224a70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06532114-ee0d-4f9b-9ef1-e9a39ec3c4ff.pdf",
            "news_date": "2026-02-11 20:34:33",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended On December On 31 2025",
            "news_body": "On review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06532114-ee0d-4f9b-9ef1-e9a39ec3c4ff.pdf",
            "news_date": "2026-02-11 20:34:33"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "On recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company appointed Mr. Paritosh Trivedi (A63623) as Company Secretary Compliance Officer and Nodal Officer of the Company with effect from February 11 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73c4faca-fd6e-4739-9a1d-24645fbb9aa3.pdf",
            "news_date": "2026-02-11 20:21:11"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday February 11 2026",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. Wednesday February 11 2026 has inter-alia;\r\n1. UNAUDITED FINANCIAL RESULTS :\r\nOn review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third quarter and Nine months ended on December on 31 2025. \r\n\r\n2. APPOINTMENT OF KEY MANAGERIAL PERSONNEL\r\nOn the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company appointed Mr. Paritosh Trivedi (A63623) as Company Secretary Compliance Officer and Nodal Officer of the Company with effect from February 11 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d3e39b5-076f-4b84-9730-bf9490a7545e.pdf",
            "news_date": "2026-02-11 19:00:59"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification Regarding Increase In Volume",
            "news_body": "With reference to the BSEs email L/SURV/ONL/PV/APJ/2025-26/908 dated February 09 2026 The Company hereby clarifies that the Company is in Compliance with Regulation 30 of SEBI (LODR) Regulations 2015 and has been promptly informing the stock exchanges on all events and information which have a bearing on operation or performance of Company. There is no undisclosed/price sensitive information or any impending announcement / corporate action which needs to be informed to the exchange at this point of time.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=001d6c25-b595-42b7-b827-0214e30cb48a.pdf",
            "news_date": "2026-02-09 12:44:52"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Concord Biotech Ltd",
            "news_body": "The Exchange has sought clarification from Concord Biotech Ltd on February 9 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-02-09 12:27:05"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Nine months ended 31 December 2025 scheduled on Thursday 12th February 2026 at 03:30 P.M. IST. The Earnings Call invite is enclosed for your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4356077-d844-4361-b8b5-531942f44d8a.pdf",
            "news_date": "2026-02-06 11:48:35"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Financial Results",
            "news_body": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=830332d2-005a-4cc9-919e-f094874c0920.pdf",
            "news_date": "2026-02-06 10:20:39"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed herewith the certificate under Regulation 74(5) of the SEBI (DP) Regulations2018 for the quarter ended 31.12.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70995b8e-a734-4185-a2f8-fbc08c9310b0.pdf",
            "news_date": "2026-01-06 10:39:14"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading window closure from 1st January2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fffad417-24f7-4ed8-b7ba-f1655558e87e.pdf",
            "news_date": "2025-12-26 09:42:30"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Ms. Hina Patel has tendered her resignation from the post of Company Secretary and Compliance Officer w.e.f 21/01/2026 after close of working  hours.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55d6c936-9fe4-433d-9b17-0cb45106c684.pdf",
            "news_date": "2025-12-24 17:28:08"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015",
            "news_body": "Change in KMPs Authorization for determining materiality of Event and Information to the Stock Exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f61a3f14-5092-42f6-9716-fba4920a0e0b.pdf",
            "news_date": "2025-12-18 13:50:44"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Mr. Raviraj Karia as CFO and KMP of the company w.e.f. 18/12/2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0301354b-a63a-40d3-9981-0458169e6ab5.pdf",
            "news_date": "2025-12-18 12:58:44"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Appointment Of CFO And KMP",
            "news_body": "Appointment of Mr. Raviraj Karia as Chief Financial Officer and KMP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f99b9643-53aa-4a5d-a092-2bf7028d8f9f.pdf",
            "news_date": "2025-12-18 12:54:19"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Early Retirement of Chief Financial officer (KMP) w.e.f.  closing of working business hours on January 052026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=588a8074-6d03-425b-8ab7-b6f1aa2dd544.pdf",
            "news_date": "2025-12-08 13:53:57"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Early retirement of Chief Financial Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdeb60e-0a65-4074-8421-d49fc2222d52.pdf",
            "news_date": "2025-12-08 13:51:04"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2FY26 earning call held on November 14 2025",
            "news_id": "f2fedc7b-e0b4-44d5-8e09-9394a07e9e47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2e1d840-994f-4249-8e2a-2721ae943b2c.pdf",
            "news_date": "2025-11-19 10:19:39",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2FY26 earning call held on November 14 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2e1d840-994f-4249-8e2a-2721ae943b2c.pdf",
            "news_date": "2025-11-19 10:19:39"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q2FY26 Earnings Call Audio",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d65112b-5457-45f3-9277-aeaae4981b17.pdf",
            "news_date": "2025-11-15 09:32:28"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper clippings of Q2 FY25-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9053a5be-401b-480b-8d5b-d3add1a80747.pdf",
            "news_date": "2025-11-14 16:10:51"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Second quarter and half year ended 30th Septembre2025",
            "news_id": "5d46ed5c-1c0a-4b2d-9069-6d44c526e987",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f934c394-3b55-470f-b81b-acb031601389.pdf",
            "news_date": "2025-11-13 22:33:39",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Second quarter and half year ended 30th Septembre2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f934c394-3b55-470f-b81b-acb031601389.pdf",
            "news_date": "2025-11-13 22:33:39"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Period Ended 30 September 2025",
            "news_body": "Approved Unaudited standalone and Consolidated financial results for the second quarter and half year ended \r\nSeptember 30 2025.",
            "news_id": "bd4aa607-de7a-40e5-968c-07e3b3276124",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae698aba-dfb5-445e-a99f-f63c2f3bc44a.pdf",
            "news_date": "2025-11-13 18:30:55",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Period Ended 30 September 2025",
            "news_body": "Approved Unaudited standalone and Consolidated financial results for the second quarter and half year ended \r\nSeptember 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae698aba-dfb5-445e-a99f-f63c2f3bc44a.pdf",
            "news_date": "2025-11-13 18:30:55"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 13/11/2025",
            "news_body": "1. Approval of Q2 FY26 Financial results \r\n2. Upon recommendation of Audit committee board approved to Invest by way of acquiring 100 % equity share\r\ncapital of M/s Celliimune Biotech Private Limited.\r\n3. Upon recommendation of Audit committee board approved invest upto Rs. 10 Crores in Captive Hybrid Solar Power Project for Limbasi Plant by entering into an agreement with relevant party.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=590620b8-71f8-4df3-a684-c839140030a8.pdf",
            "news_date": "2025-11-13 18:21:31"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2025 scheduled on Friday 14th November 2025 at 03:30 P.M. IST. The Earnings Call invite is enclosed for your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=649657ca-b9c6-4ba7-855e-68fc53fd8a5a.pdf",
            "news_date": "2025-11-08 13:48:47"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Results",
            "news_body": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b36f116c-d88d-44ba-aca1-4728e29444a1.pdf",
            "news_date": "2025-11-08 09:28:38"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Successful Completion Of NAFDAC Inspection",
            "news_body": "Intimation of Successful Completion of NAFDAC Inspection at our Oral Solid Dosage Unit-2 facility located at Valthera",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15650960-7220-4992-b08c-5159edbfcbf5.pdf",
            "news_date": "2025-10-08 11:04:17"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) regulations 2018 for the quarter ended 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca815b57-a5e0-4ab7-8cb6-aa84c2a8c7b3.pdf",
            "news_date": "2025-10-06 17:16:38"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2b4ae45-bd64-4a7c-a026-def07892c9ad.pdf",
            "news_date": "2025-09-25 10:02:12"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 on 19th September 2025 at 11:00 AM IST",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3caf60f-4f51-4908-8d62-de9972b62e37.pdf",
            "news_date": "2025-09-11 15:18:18"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 on 17th September 2025 at 10:00 AM IST",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3d08627-16a6-48ba-999d-6fd3304b0d64.pdf",
            "news_date": "2025-09-11 15:14:18"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Pursuant to provision 44(3) of SEBI LODR 2015 Please find enclosed herewith details of Voting result of 40thAGM and Scrutinizers Report on E-voting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e61f9d6-be4f-4579-a5af-1b2c1b31c96d.pdf",
            "news_date": "2025-09-11 14:49:29"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Regulation 30 of the SEBI (LODR) Regulation 2015 we hereby enclose the summary of the proceedings of AGM held on Tuesday 9 September 2025 through Video Conferencing (VC)/ other audio-visual Means (OAVM)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6325f32-8824-4d0d-aa4c-f3331cd10d6c.pdf",
            "news_date": "2025-09-09 17:53:20"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Successful Completion Of EU GMP Inspection",
            "news_body": "Intimation of successful completion of European Union Good Manufacturing Practices (EU GMP) inspection at our API facility in Limbassi",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fb0d8a4-9725-4777-ba04-a4831c49944a.pdf",
            "news_date": "2025-08-21 14:12:52"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning call held on August 11 2025",
            "news_id": "9383fb95-312c-402e-b7bc-e3def6a669d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addbb564-28e8-4082-9a21-e5db2523d4b7.pdf",
            "news_date": "2025-08-18 18:14:34",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning call held on August 11 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addbb564-28e8-4082-9a21-e5db2523d4b7.pdf",
            "news_date": "2025-08-18 18:14:34"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper clipping of 40th Annual general Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac07de09-21ac-4344-b28a-f7cef136b795.pdf",
            "news_date": "2025-08-14 11:54:36"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Enclosed herewith BRSR for FY 2024-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6a0ae63-568b-4e98-b39a-12823d704134.pdf",
            "news_date": "2025-08-13 14:41:20"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": " Annual report- Disclosure under Regulation 34 of SEBI(LODR) Regulation 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ca5abb-d3bf-4dc0-8046-fba658ad2e1e.pdf",
            "news_date": "2025-08-13 11:38:13"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of 40Th Annual General Meeting Notice",
            "news_body": "40th Annual general Meeting to be held on 9th September 2025 at 4:00 PM through OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c961697b-0599-4ff0-bce4-07ef1a8bf55f.pdf",
            "news_date": "2025-08-13 11:30:55"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement Clipping  for 40th Annual General Meeting Record date for Dividend and E-Voting Information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ceb1be-dada-4033-992c-8befbf40becd.pdf",
            "news_date": "2025-08-12 14:42:07"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q1FY26 Earnings Call Audio",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8c23dc6-d161-45ae-a88e-d034d0a7d228.pdf",
            "news_date": "2025-08-11 18:31:56"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results for the Q1 FY25-26",
            "news_id": "7f93b636-2672-4d89-9775-9a9b112fa5a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f54b2085-70a6-491f-b5ce-a4d920857a6d.pdf",
            "news_date": "2025-08-10 12:44:35",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results for the Q1 FY25-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f54b2085-70a6-491f-b5ce-a4d920857a6d.pdf",
            "news_date": "2025-08-10 12:44:35"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper clipping of Q1 FY25-26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68b9b25f-2108-4aac-9805-dfcc5f634975.pdf",
            "news_date": "2025-08-10 10:14:39"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Q1 FY 2025-2026",
            "news_body": "Financial Results Q1 FY 2025-2026",
            "news_id": "5573aa2e-e0ba-47cf-970b-c297a02eccfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53671625-8568-438f-a27c-13cdc3698d15.pdf",
            "news_date": "2025-08-08 17:16:13",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results Q1 FY 2025-2026",
            "news_body": "Financial Results Q1 FY 2025-2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53671625-8568-438f-a27c-13cdc3698d15.pdf",
            "news_date": "2025-08-08 17:16:13"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date",
            "news_body": "Record date for final dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ce57133-66ef-4ec2-8b7d-bad9b14dddb8.pdf",
            "news_date": "2025-08-08 16:46:33"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting held today  Friday August 08 2025- Unaudited Financial Results for the First quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd648b8-1d89-4488-879d-7420bf41bd58.pdf",
            "news_date": "2025-08-08 16:44:28"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the First quarter ended on 30th June 2025 scheduled on Monday 11th August 2025 at 04:00 P.M. IST. The Earnings Call invite is enclosed for your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a69e973c-46a8-4c12-8963-d2b47ab81105.pdf",
            "news_date": "2025-08-05 09:49:23"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results For The First Quarter Ended On June 30 2025 Along With Limited Review Report",
            "news_body": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the First quarter ended on June 30 2025 along with limited review report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b059116-e1fc-45c8-af49-f58778f36e39.pdf",
            "news_date": "2025-08-04 09:42:59"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Successful Completion Of Russian GMP Inspection",
            "news_body": "Intimation of successful completion of Russian GMP inspection at our API Facility in Dholka",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed1f7847-cc89-4b64-9a11-e213a858d21c.pdf",
            "news_date": "2025-07-26 09:47:50"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "We are pleased to announce Incorporation of Concords Wholly owned Subsidiary company namely Concord Lifegen Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fd4ccf9-376c-45a3-ad9c-30ea134b3a82.pdf",
            "news_date": "2025-07-22 18:53:05"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Successful Completion Of EU GMP Inspection",
            "news_body": "Intimation of completion of European Union Good Manufacturing Practices (EU GMP) Inspection at our API Facility in Dholka",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3b1192d-b322-4714-a744-295bd29420fe.pdf",
            "news_date": "2025-07-18 13:06:33"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) Regulations2018 for the quarter ended 30.06.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=246c8b54-d8b4-4ad5-87a1-cbf6a07164fc.pdf",
            "news_date": "2025-07-08 09:24:11"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Concord Biotech Limited has made Investment of USD 1500 in Stellon Biotech Inc.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a4a1a80-8f62-47ae-a081-d5b0629dba22.pdf",
            "news_date": "2025-07-02 10:23:25"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=606d481e-8359-453f-8421-a5cca950d136.pdf",
            "news_date": "2025-06-25 14:57:00"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On The USFDA Inspection At The Companys API Facility At Dholka",
            "news_body": "Concord Biotech limited receives Establishment Inspection Report (EIR) for its API facility at Dholka",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aca48f78-a97e-4b4f-a2bc-1d756916244c.pdf",
            "news_date": "2025-06-24 13:40:14"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Conference Call held on 30th May 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83e1980-61c3-4e31-ab22-68b8c1eb05c7.pdf",
            "news_date": "2025-06-06 10:17:24"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Pursuant To Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Disclosure under Regulation 30(5) of SEBI (LODR) Regulations2015 Authorization for determining Materiality of Events and Information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62094b4a-73c2-4082-ae6e-a515e57aa4d9.pdf",
            "news_date": "2025-06-02 17:58:20"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled on 10th June 2025 at 09:00 AM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f80e47b-a4db-4c21-9587-ce5ec56141aa.pdf",
            "news_date": "2025-06-02 17:36:46"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled on 09th June 2025 at 10:00 AM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b88ff971-dd54-42c9-9e31-6df65020bc66.pdf",
            "news_date": "2025-06-02 17:31:59"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publications of Financial Results Q4 & FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=270a2b53-4978-426c-bbb7-284b366389e6.pdf",
            "news_date": "2025-05-31 14:00:12"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 and further to our intimation dated May 27 2025 to the Stock exchanges regarding Earning call in respect of the Audited (Standalone and Consolidated) Financial Results of the company for quarter and year ended March 31 2025 we wish to inform that the said Earning Call was held today at 02:30 PM (IST).\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4231a07-6f04-400d-a36e-ce6dd66900b2.pdf",
            "news_date": "2025-05-30 18:35:38"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Pursuant to regulation 30 of SEBI(LODR)2015 on financial results for the quarter and year ended on 31st March 2025",
            "news_id": "c8d15b9c-cd15-4a21-8f4a-5ca29925d00c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f294d177-d40e-4b02-b999-cdaa5e026110.pdf",
            "news_date": "2025-05-30 11:19:47",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Pursuant to regulation 30 of SEBI(LODR)2015 on financial results for the quarter and year ended on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f294d177-d40e-4b02-b999-cdaa5e026110.pdf",
            "news_date": "2025-05-30 11:19:47"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial compliance report for the Financial year 2024-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4622bcf2-d8f2-4e72-ae39-986d9aa40619.pdf",
            "news_date": "2025-05-29 21:12:35"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Auditors",
            "news_body": "Appointment of Secretarial Auditors Appointment of Internal Auditors and Appointment of Cost Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cae247a5-2731-41f1-8a3c-a7e7d28d48e2.pdf",
            "news_date": "2025-05-29 19:54:21"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "On recommendation of NRC the board of directors of the company appointed Ms. Hina Patel(M.No-A56541) who is already in employment of the company. She is appointed as a company secretary and compliance officer of the company as Key managerial personnel of the company with effect from 30th May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d330717-e08e-4149-a931-fb09cd7b72cd.pdf",
            "news_date": "2025-05-29 19:48:31"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "The board  has recommended dividend of Rs.10.70 per equity share of face value of Rs. 1 per share for the financial year 2024-25 subject to approval by shareholders of the company at the ensuing AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c14f4d3-1afe-4d4b-814b-9a86cdf371f4.pdf",
            "news_date": "2025-05-29 19:39:29"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result",
            "news_body": "Financial result for Q4 and year ended on 31st March 2025",
            "news_id": "9ab6026e-4191-4e6f-b4d5-e2ff912c20ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52c992cc-a815-4891-b57c-61d4e1d61d67.pdf",
            "news_date": "2025-05-29 19:28:15",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result",
            "news_body": "Financial result for Q4 and year ended on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52c992cc-a815-4891-b57c-61d4e1d61d67.pdf",
            "news_date": "2025-05-29 19:28:15"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May2025",
            "news_body": "Outcome of Board Meeting held today i.e. Thursday May 29 2025- To Audited Financial\r\nResults for the quarter and Financial Year ended on March 31 2025 and to approve other agendas.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90fdde1b-a190-47c6-939b-944b94122297.pdf",
            "news_date": "2025-05-29 19:12:22"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Revised Earning call Intimation. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto we wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Audited Standalone and Consolidated Financial Results of the Company for the Fourth quarter and year ended 31st March 2025 scheduled on Friday 30th May 2025 at 02:30 P.M. IST. The Earnings Call invite is enclosed for your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dff6507d-d4a6-43eb-b6c0-e3077398324b.pdf",
            "news_date": "2025-05-27 09:38:28"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto we wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Audited Standalone and Consolidated Financial Results of the Company for the Fourth quarter and year ended 31st March 2025 scheduled on Friday 30th May 2025 at 04:00 P.M. IST.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47402751-dc89-4e15-9a22-157c70a39836.pdf",
            "news_date": "2025-05-26 15:59:19"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Approval Of Audited Financial Statements For The Quarter And Year Ended March 31 2025.",
            "news_body": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve the audited Standalone and Consolidated Financial results of the company for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c366b7ec-a3ab-41cb-9e0e-1f37089b1383.pdf",
            "news_date": "2025-05-23 17:47:42"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Pursuant to Reg 30 of the SEBI(LODR) 2015 this is to inform that CS Prakash Sajnani vide letter dated 13/05/2025 has tendered his resignation from the post of Company Secretary and compliance officer with effect from 29/05/2025 after closure of working hours.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55237720-4f94-4449-9309-0cf49314c64d.pdf",
            "news_date": "2025-05-13 19:01:21"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Completion Of Inspection By United States Food And Drug Administration (USFDA) Of Our API Facility At Dholka.",
            "news_body": "The Company has announced the completion of the United States Food and Drug Administration (USFDA) inspection of our API facility at Dholka. The Inspection took place from April 28 to May 2 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf9c741f-d94b-4f08-ac7a-23da929da473.pdf",
            "news_date": "2025-05-02 17:24:20"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed herewith the certificate under regulation 74(5) of the SEBI(DP) Regulation2018 for the quarter ended 31.03.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cde5f143-c660-4e87-a888-ef304475cc23.pdf",
            "news_date": "2025-04-09 12:51:28"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Of SEBI (LODR) Regulations 2015 Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval To Market Teriflunomide Tablets 7 Mg And 14 Mg In The US",
            "news_body": "The company has been granted final approval from the USFDA for marketing its Teriflunomide tablets 7mg and 14mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e81329d7-038a-44e0-a5a7-a7277a8b0eb1.pdf",
            "news_date": "2025-04-08 18:00:38"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Commencement Of Commercial Production At Unit-4 Valthera",
            "news_body": "Enclosed herewith announcement about successfully commissioned and commenced production of Injectable at our   Manufacturing facility situated at Valthera.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5c8ee35-5de9-464b-97d9-1c6fc3693ead.pdf",
            "news_date": "2025-03-25 11:06:03"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Trading window for dealing in securities of the company will be closed for all designated person and their immediate relatives with effect from 1st April 2025 and the same will remain closed till 48 hours after the announcement of Audited financial results for month and quarter ended on 31st March 2025. Kindly take on records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49702b93-2871-4255-a893-578486050f9c.pdf",
            "news_date": "2025-03-22 14:26:19"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 on 21st March 2025 in New york USA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b24b8546-e19e-4c02-ad6e-d7e5dfa32b1f.pdf",
            "news_date": "2025-03-18 13:51:40"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled on 13th March 2025 at 8:45 AM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41ea6942-d635-499c-b264-f2fbe913be32.pdf",
            "news_date": "2025-03-10 17:34:51"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for TO Make INVESTMENT IN M/S CLEAN MAX EVERGLADES PVT LTD FOR INSTALLATION OF HYBRID RENEWABLE ENERGY PLANT",
            "news_body": "To Invest in M/s Clean Max Everglades Private limited Rs. 60958836/- through Right Issue for installation of Hybrid renewable energy Plant",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=984c48ba-91fa-40a2-aff8-e2ec7d390d12.pdf",
            "news_date": "2025-03-04 11:31:02"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled on 6th March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1679ac0-2330-456f-ae21-f1a9a657a36d.pdf",
            "news_date": "2025-03-01 10:38:05"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e78449e3-86a6-49f3-bc83-29194ce6020c.pdf",
            "news_date": "2025-02-22 09:42:40"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed herewith the transcripts of Q3/9M-FY25 Earning Call held on the 14th February 2025",
            "news_id": "c486c8a5-4def-4cef-b096-1235aaf9a398",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2331ef6f-b29f-45a9-8504-a240ea1b4f36.pdf",
            "news_date": "2025-02-21 10:18:09",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed herewith the transcripts of Q3/9M-FY25 Earning Call held on the 14th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2331ef6f-b29f-45a9-8504-a240ea1b4f36.pdf",
            "news_date": "2025-02-21 10:18:09"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation About Completion Of Inspection By Ministry Of Food And Drug Safety (MFDS) At Dholka (Unit I) Of The Company.",
            "news_body": "Enclosed herewith Intimation regarding successful completion of Inspection by Ministry of Food and Drug Safety (MFDS) at Manufacturing Unit-1 situated at Dholka.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9643f29f-8a8f-48d4-ad9a-33855377342c.pdf",
            "news_date": "2025-02-20 14:28:31"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please Find enclosed herewith extracts of Unaudited Standalone and consolidated Financial Results for the Third quarter and Nine Months ended on December 31 2024 published in Financial Express newspaper on 15th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cf95a5f-d711-4b86-b37f-21bf0c17c706.pdf",
            "news_date": "2025-02-15 13:12:10"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 and further to our intimation dated January 31 2025 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for third quarter and Nine Months ended December 31 2024 we wish to inform that the said Earning Call was held today at 04:00 PM (IST).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b50cd2f5-e6b0-4071-a378-ebdf0a4c7afb.pdf",
            "news_date": "2025-02-14 18:46:25"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Financial results for the Third Quarter and nine months ended on 31st December2024 is enclosed herewith for record.",
            "news_id": "21eb7b1e-eede-4f86-8393-8e517c904b26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a663e669-b4cc-4831-bc9a-6beb45d3745c.pdf",
            "news_date": "2025-02-14 10:51:57",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Financial results for the Third Quarter and nine months ended on 31st December2024 is enclosed herewith for record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a663e669-b4cc-4831-bc9a-6beb45d3745c.pdf",
            "news_date": "2025-02-14 10:51:57"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated filling of financial results for the quarter and nine months period ended on 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59011559-623e-4b12-b83a-1d825dccb472.pdf",
            "news_date": "2025-02-13 19:42:11"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Financial Results For The Period Ended 31 December 2024",
            "news_body": "Pursuant to  Regulation 30 and 33 of SEBI (LODR) regulations 2015 as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the Third quarter and nine months ended on December 31 2024 along with the limited review reports with Unmodified Opinion Issued by M/s. BSR & Co. LLP The statutory Auditor.",
            "news_id": "3e25e778-14c9-4b1c-bd1b-4ebff40f3956",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8999cf0-e721-457c-be27-ee1974558c1c.pdf",
            "news_date": "2025-02-13 19:37:44",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": " Financial Results For The Period Ended 31 December 2024",
            "news_body": "Pursuant to  Regulation 30 and 33 of SEBI (LODR) regulations 2015 as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the Third quarter and nine months ended on December 31 2024 along with the limited review reports with Unmodified Opinion Issued by M/s. BSR & Co. LLP The statutory Auditor.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8999cf0-e721-457c-be27-ee1974558c1c.pdf",
            "news_date": "2025-02-13 19:37:44"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for  Financial Results For The Period Ended 31 December 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the Third quarter and Nine months ended on December 31 2024 along with the Limited Review Report with Unmodified Opinion issued by M/s. BSR & Co. LLP the Statutory auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4940828b-f356-4f32-9af7-44d28c2d4cc6.pdf",
            "news_date": "2025-02-13 19:28:54"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended 31st December 2024 scheduled on Friday 14th February 2025 at 04:00 P.M. IST.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=930beb90-9fa2-46ef-a2a7-5b2de9cc78bf.pdf",
            "news_date": "2025-01-31 14:48:08"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Results",
            "news_body": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve  the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a7214ad-c3c1-4f06-a266-bf5f9a508c9b.pdf",
            "news_date": "2025-01-24 10:12:17"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Revised:  M/s Concord Biotech Limited (Company) has today entered into a Share Purchase Agreement (SPA) with Clean Max Everglades Private Limited (Clean Max) and Clean Max Enviro Energy Solution Private Limited (CMEESPL) whereby the company will acquire 26% equity shares of clean Max from CMEESPL.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dab581e-3759-4da7-b617-49cc4b9a86a3.pdf",
            "news_date": "2025-01-16 16:42:38"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "M/s Concord Biotech Limited (Company) has today entered into a Share Purchase Agreement (SPA) with M/s Clean Max Everglades Limited (Clean Max) and M/s Clean Max Enviro Energy Solutions Private Limited (CMEESPL) whereby the Company will acquire 26% equity shares of Clean Max from CMEESPL.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=753826fb-ef76-4548-9ad2-5f868f556781.pdf",
            "news_date": "2025-01-16 15:57:11"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We enclosed herewith the certificate under Regulation 74(5) of the SEBI (DP) regulation 2018 for the quarter ended 31.12.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=850d3f54-f16e-4c60-84c3-25a22e5d8d82.pdf",
            "news_date": "2025-01-11 09:44:42"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Company Update",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "M/s Concord Biotech Limited has made Investment of USD 1,000,000 in Compulsorily Convertible Notes of M/s  Palvella Therapeutics, Inc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99a3f300-e6da-46dc-821d-4c31c8221f6d.pdf",
            "news_date": "2024-12-12 11:41:34"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcripts of the earning calls for the second quarter ended 30 September 2024 is enclosed herewith. Kindly take the same into your records.",
            "news_id": "f5d2b5d8-c21d-4003-8ad9-ab76d6513f3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b067a150-a0a4-454a-9225-2566e17b404a.pdf",
            "news_date": "2024-11-19 11:20:48",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcripts of the earning calls for the second quarter ended 30 September 2024 is enclosed herewith. Kindly take the same into your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b067a150-a0a4-454a-9225-2566e17b404a.pdf",
            "news_date": "2024-11-19 11:20:48"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 22nd November, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8e0000c-df2d-4953-8518-b165d3a9e658.pdf",
            "news_date": "2024-11-14 11:26:07"
        },
        {
            "co_code": 72610,
            "bse_code": 543960,
            "isin": "INE338H01029",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 21st November, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcac35d1-3789-45c9-9de8-e446ceed870f.pdf",
            "news_date": "2024-11-14 11:22:26"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI(LODR)Regulations, 2015 Investor Presentation on financial results for the second quarter and half year ended 30th September,2024 is enclosed. Kindly take note the records",
            "news_id": "d34ccc7f-668c-45ec-b03f-40c2f30098e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7e8f418-0766-43ce-a12b-d396a218b37a.pdf",
            "news_date": "2024-11-11 18:23:00",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of the SEBI(LODR) regulations, 2015, as amended from time to time, we enclosed herewith the unaudited standalone and consolidated financial statement for the second quarter and half year ended September 2024, along with the limited review report with unmodified opinion issued by M/s. BSR & co. LLP, the statutory auditors.",
            "news_id": "2968dece-cd3a-4dc0-ae8a-17a6b8172ffd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5c37c2-6f71-43c9-a9e4-3d7bb83d9f55.pdf",
            "news_date": "2024-11-11 13:08:07",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith.kindly take the same into your records.",
            "news_id": "616d84eb-e50f-4b67-8578-8090796e38b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd223f7b-18e4-401e-bbad-966b3a7d7533.pdf",
            "news_date": "2024-08-20 16:10:29",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosedKindly take the above on records",
            "news_id": "45c2a93e-8f30-4358-8bd9-3f8120a660b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7020862e-ef39-4ed5-8d4a-3d94d5e1c5e0.pdf",
            "news_date": "2024-08-10 17:49:49",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For 30/06/2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Statement for the first quarter ended june 30, 2024",
            "news_id": "ebce67a7-6a7b-4091-a803-f8df153f6546",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=def49d36-65f3-45b4-b277-fb476fecf70c.pdf",
            "news_date": "2024-08-09 13:41:19",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcripts of Q4 & FY24 Earning call Held on May 28, 2024",
            "news_id": "8698138b-9104-4762-8d93-f16fa1c5acaa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc48dcb9-a037-4f5b-a7cc-0fcf19011fb2.pdf",
            "news_date": "2024-06-04 11:12:07",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records.",
            "news_id": "12386946-2186-4ec9-89a1-cae549db89b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=414bb397-9c21-4af6-8d1d-b8d6c22f4b85.pdf",
            "news_date": "2024-05-28 18:52:51",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.",
            "news_id": "5f50ad1e-4f2c-492a-9704-efa882da9e02",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d50132e-2d1e-4e4f-9cf6-2a7d3334fc5b.pdf",
            "news_date": "2024-05-27 18:21:08",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024",
            "news_body": "Outcome of Board meeting held today i.e thursday may 23,2024- Audited Financial Results for the quarter and financial year ended on March 31, 20241",
            "news_id": "63948fb3-e651-46d5-bc49-cfef6bb3f521",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e421ebd-5edf-4ba5-a85e-b84f5f0927c5.pdf",
            "news_date": "2024-05-23 15:36:46",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In Continuation of our letter dated February 09, 2024 regarding audio recording of the unaudited (Standalone and Consolidated) financial results of the company for the Third Quarter and Nine months ended December 31, 2023 , transcripts of the earnings call for the said period enclosed herewith and available on the website of the company at the following link after sending this letter to you,https://www.concordbiotech.com/investors",
            "news_id": "6f22e856-7f4d-4023-a669-07540fa93edb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8098c1-b016-4bd2-b819-9ca4582d883f.pdf",
            "news_date": "2024-02-16 12:11:21",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2024 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Third Quarter and Nine Months ended December 31, 2023, we wish to inform that the said Earning Call was held today at 02:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/q3fy24-earnings-audio-20240209175243.mp3 Kindly take the above on records.",
            "news_id": "55bba4fe-15ba-45f9-be56-8e53dd99d831",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0882b952-a87b-4455-bf61-eabfc9b639b8.pdf",
            "news_date": "2024-02-09 18:25:24",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Schedule III Part A of  SEBI (LODR) Regulations, 2015, investors presentation on the financial results for the Third Quarter and Nine months ended  December 31, 2023 is enclosed.",
            "news_id": "c3e25952-a6e4-486e-aae4-2277b5d7567b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5465ade3-836d-4325-aeec-0a78a0e382ea.pdf",
            "news_date": "2024-02-09 10:27:37",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended December 31, 2023",
            "news_body": "with reference to the intimation of Board meeting submitted on January 30, 2024, we would like inform you that the Board of Directors of the company , at its meeting held today i.e. Thursday, February 08, 2024, has inter-alia approved unaudited standalone and consolidated financial results for the third quarter and nine months ended on December 31, 2023.",
            "news_id": "97800eb4-e31a-42ea-921a-7a1864eade3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1a456e7-9518-4655-b158-928a2ffab1eb.pdf",
            "news_date": "2024-02-08 18:15:57",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In Continuation of our letter dated November 09, 2023 regarding audio recording of the Unaudited (Standalone and consolidated) Financial results of the company for the quarter and half year ended September 30, 2023, Earnings call for investors and analysts and pursuant to regulation 30(6) of SEBI LODR, the transcripts of the earning call for the said period enclosed herewith.",
            "news_id": "ae981744-f28b-4d8e-ad91-e52c4b6caded",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acc254aa-b4db-4166-a5e5-90aac98859ff.pdf",
            "news_date": "2023-11-16 15:35:45",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated October 31, 2023 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Quarter and half year ended September 30, 2023, we wish to inform that the said Earning Call was held today at 03:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q2FY24-Earnings-call-audio.mp3 Kindly take the above on records",
            "news_id": "57947ad9-42f5-4089-950a-2bf1288a8c51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ad0039d-60f5-4e29-be78-d556a05301d4.pdf",
            "news_date": "2023-11-09 18:46:01",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of Schedule III Part A of  SEBI (Listing Obligations and disclosure requirements) Regulations, 2015, investors presentation on financial results for the quarter and half year ended on September 30, 2023 is enclosed.",
            "news_id": "5abb6b32-c849-40f3-b2a5-e4247d0ef106",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ad51594-78eb-44e9-8596-1086644f93a5.pdf",
            "news_date": "2023-11-08 18:53:28",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "With reference to the intimation of Board meeting submitted on October 25, 2023, we would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Wednesday, November 08, 2023, has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023. The said results were also reviewed by the Audit Committee of the Company in its meeting held on November 08, 2023.<BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023, along with the Limited Review Report of the Statutory auditors.<BR> <BR> The Board Meeting commenced at 11:00 AM and concluded at 03:00 P.M.<BR>",
            "news_id": "d47c5de7-dfab-4706-9b90-c8822c8da93c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d9a4f5e-3de5-44a6-85de-17e4d9cafa3f.pdf",
            "news_date": "2023-11-08 15:29:19",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E Wednesday, November 08, 2023- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "we would like to inform you that the Board of Directors of the company at its meeting held today i.e. Wednesday, 08th November, 2023 has inter-alia approved unaudited standalone and consolidated financial results for the quarter and half year ended september 30, 2023. the said results were also reviewed by the audit committee of the company in its meeting held on 08th November, 2023",
            "news_id": "78df3aba-67a4-4d64-8366-1e2992942911",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41aceab6-bfa6-48a8-bdce-7c7065676954.pdf",
            "news_date": "2023-11-08 15:19:03",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated September 07, 2023 regarding audio recording of Q1FY 24 earning call for investor and anaysts and pursuant to regulation 30(6) of SEBI LODR, Please find enclosed transcripts of  Q1 FY 24 earning call for the Quarter ended on June 30, 2023",
            "news_id": "59d357a7-c5f2-4f91-a1fd-addbb4b9456d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a010362-24c5-4b39-83f1-87b465d43b52.pdf",
            "news_date": "2023-09-13 16:17:01",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, and further to our intimation dated September 01, 2023 to the exchange regarding Earning call in respect of the Unaudited Financial Results of the company for the Quarter ended June 30, 2023, we wish to inform that the said Earning Call was held today at 4:00 PM (IST).The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :-  https://www.concordbiotech.com/public/assets/pdf/Q1FY24-Earnings-call.mpegKindly take the above on records.",
            "news_id": "dc1c65a3-ca32-46be-80d7-8e0910382e36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49086af9-f0c9-46ff-941f-0f8eb7061347.pdf",
            "news_date": "2023-09-07 18:22:25",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CONCORDBIO",
            "disp": "Concord Biotech",
            "bse_code": 543960,
            "isin": "INE338H01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, a results presentation to analyst/investor for the period ended June 30,  2023 is enclosed.Kindly take the above on records.",
            "news_id": "fd3c2212-c7a0-4f07-b13c-acda73b7458b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e0f43a1-7f84-4f77-925f-6e1d719e109c.pdf",
            "news_date": "2023-09-06 20:25:02",
            "seo": "concord-biotech-ltd",
            "ltp": 1244.8,
            "ch": -37.5,
            "pch": -2.924432660063948,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 18060,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}